Targeting NAD-dependent dehydrogenases in drug discovery against infectious diseases and cancer.
Biochem Soc Trans
; 48(2): 693-707, 2020 04 29.
Article
em En
| MEDLINE
| ID: mdl-32311017
ABSTRACT
Dehydrogenases are oxidoreductase enzymes that play a variety of fundamental functions in the living organisms and have primary roles in pathogen survival and infection processes as well as in cancer development. We review here a sub-set of NAD-dependent dehydrogenases involved in human diseases and the recent advancements in drug development targeting pathogen-associated NAD-dependent dehydrogenases. We focus also on the molecular aspects of the inhibition process listing the structures of the most relevant molecules targeting this enzyme family. Our aim is to review the most impacting findings regarding the discovery of novel inhibitory compounds targeting the selected NAD-dependent dehydrogenases involved in cancer and infectious diseases.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oxirredutases
/
Doenças Transmissíveis
/
Descoberta de Drogas
/
NAD
/
Neoplasias
Tipo de estudo:
Prognostic_studies
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Biochem Soc Trans
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Itália